Robocath adds $2m for new neurovascular platform

This article was originally published here
Share

RobocathMedical robotics startup Robocath said today that it added about $2 million (€1.7 million) to the more than $5 million it raised earlier this year, taking its total to $7.5 million in funding this year.

Rouen, France-based Robocath, which is developing the R-One robotic platform for coronary angioplasty, is pursuing CE Mark approval in the European Union for the system. R-One is expected to hit the market in Europe and the Middle East next year, the company said.

Get the full story at our sister site, The Robot Report.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply